Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000512833 | SCV000224313 | uncertain significance | not provided | 2014-12-29 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000281876 | SCV000399302 | uncertain significance | Brittle cornea syndrome 1 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000512833 | SCV000532246 | benign | not provided | 2020-03-25 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000512833 | SCV000608781 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | ZNF469: BP4, BS2 |
Institute for Genomic Medicine |
RCV000173218 | SCV000864303 | likely benign | not specified | 2017-08-22 | criteria provided, single submitter | clinical testing | BS1, BP4; This alteration has an allele frequency that is greater than expected for the associated disease, and is predicted to be tolerated by multiple functional prediction tools. |
Labcorp Genetics |
RCV000512833 | SCV002402563 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002277327 | SCV002565313 | benign | Ehlers-Danlos syndrome | 2022-06-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002426825 | SCV002741424 | likely benign | Cardiovascular phenotype | 2019-01-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |